Healthcare
Possible ban on flavoured cigarettes will not affect tourism: gov’t
Authorities emphasise that Hong Kong visitors go to the city not to smoke.
Possible ban on flavoured cigarettes will not affect tourism: gov’t
Authorities emphasise that Hong Kong visitors go to the city not to smoke.
Govt to roll out new tobacco control measures
The government will also add more no-smoking areas.
GUTolution’s custom probiotics address unique gut health needs
The start-up uses shotgun metagenomic sequencing to analyse a person’s gut microbiome.
Gov't creates office for medical products regulation planning
The body will review existing laws for possible amendments.
Novotech, HSITPL sign agreement for biotech support in HK-Shenzhen park
Novotech is one of 14 international firms selected to partner with HSITPL.
RAISe+ Scheme backs Immuno Cure's HCC antibody development
The scheme will fund product development and commercialisation.
Dr. So Wing-yee named hospital chief executive of North District Hospital
She brings extensive experience in healthcare management at corporate and cluster levels.
Gov’t to roll out new dental queuing system
This will begin June 11.
New Frontier acquires Hong Kong Integrated Oncology Centre
HKIOC offers cancer treatment, TomoTherapy, and mammography services.
CUHK study finds cognitive activities benefit older adults' brain health
It also decreases the risk of dementia in older people.
Govt signs pact to promote innovation of Chinese medicines
The partnership will utilise talent and technical exchanges.
Gov’t OKs Pfizer’s dual indication vaccine vs. respiratory syncytial virus
This is the first bivalent, single-dose vaccine against RSV.
Health Bureau renews drug regulation agreement
The government will also establish a clinical trial facility in Hetao this year.
CUHK develops tool for early hypoglycemia warnings amongst high-risk adults
The faculty analysed a dataset from the HADCL from 2013 to 2018.
Swire Pacific acquires controlling stake in DeltaHealth
The company signed definitive agreements to increase its stake in March.
Health department greenlights Nefecon for adult IgAN Patients
Hong Kong is the fourth jurisdiction that approved the use of Nefecon.
Hong Kong and Shanghai eye stronger healthcare collaboration
The two will push forward the “Healthy China” initiative.
Read Here
Advertise
Sign Up
